# Triprolidine + Pseudoephedrine

## Pseu solution 60mL (0.25+6mg/mL)

| TAH Drug Code      | [LPSE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LPSE)                                                                                                                                                                                                                                                                                 |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Temporary relief of symptoms (runny nose, nasal congestion, sneezing, itchy nose or throat, itchy/watery eyes, nasal passages swelling) associated with common cold, hay fever (allergic rhinitis), or other upper respiratory allergies.                                                                                                            |
| Dosing             | Ingredient content: Triprolidine 0.25 mg/mL + Pseudoephedrine 6 mg/mL Adults and Children ?12 years: 10 mL every 4-8 hours as needed; MAX 4 doses (40 mL) per 24 hours. Children 6 to <12 years: 5 mL every 4-8 hours as needed; MAX 4 doses (20 mL) per 24 hours. Children 2-5 years: 2.5 mL/dose. Children 6 months - under 2 years: 1.25 mL/dose. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to Pseu solution, pseudoephedrine, triprolidine or any component of the formulation.                                                                                                                                                                                                                                                |
| Adverse Effects    | Tachycardia, dizziness, drowsiness, excitement (transient), fatigue, headache, insomnia, nervousness, diaphoresis, weight gain, abdominal pain, diarrhea, increased appetite, nausea, xerostomia, dysuria, arthralgia, weakness, pharyngitis, thickening of bronchial secretions.                                                                    |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/triprolidine-and-pseudoephedrine-drug-information)                                                                                                                                                                                                                                                      |

